Indications and uses
For the temporary relief of symptoms due to acute and chronic Sinus Infection: Sinus Headaches Post Nasal Drip Nasal Congestion
For the temporary relief of symptoms due to acute and chronic Sinus Infection: Sinus Headaches Post Nasal Drip Nasal Congestion
Adults and children 12 years and older 2 sprays to each nostril, 3-5 times per day Children between 12 years and 6 years of age 1 spray to each nostril, 3-5 times per day Children under 6 years 1 spray to each nostril, 3 times per day
ALIUM CEPA 6X, 8X, 12X EXPECTORANT
ALTHEA OFFICINALIS 2X EXPECTORANT
ARGENTUM NITRICUM 10X HEADACHE ANALGESIC
ASCORBIC ACID 2X ANTIOXIDANT
BLACK CURRANT 1X DETOXIFICATION
COMMON LUNGWORT 2X DECONGESTANT
CUPRUM METALLICUM 3X ANTIVIRAL IMMUNE SUPPORT
ECHINACEA ANGUSTIFOLIA 3X ANTIBACTERIAL IMMUNE SUPPORT
HEPAR SULFURIS CALCAREUM 6X, 8X, 12X ANTIOXIDANT
HYDRASTIS CANADENSIS 6X, 8X, 12X MUCOLYTIC
KALI BICHROMICUM 6X, 8X, 12X MUCOLYTIC
LACHESIS MUTUS 12X, 30X, 200X DECONGESTANT
MANGANUM METALLICUM 3X DECONGESTANT
MERCURIUS SULPHURATUS RUBER 6X, 8X, 12X ANTI-INFLAMMATORY
MUCOSA NASALIS 6X, 12X, 30X SUPPORTS IMMUNE RESPONSE
PLANTAGO MAJOR 2X DETOXIFICATION
PULSATILLA 6X, 8X, 12X DECONGESTANT
SILICEA 6X, 8X, 12X DECONGESTANT
SINUSITISINUM 12X, 30X DECONGESTANT
THYMUS GLAND 6X, 12X, 30X SUPPORTS IMMUNE RESPONSE
URINARY BLADDER 10X, 30X, 200X DETOXIFICATION
For the temporary relief of symptoms due to acute and chronic Sinus Infection:
If pregnant or breast-feeding ask a doctor before use
Keep out of reach of children.
Adults and children 12 years and older 2 sprays to each nostril, 3-5 times per day
Children between 12 years and 6 years of age 1 spray to each nostril, 3-5 times per day
Children under 6 years 1 spray to each nostril, 3 times per day
Questions?: info@gunainc.com
Tel. (484) 223-3500
Inactive ingredient: orange juice, potassium sorbate, sodium benzoate, water.
Directions:
tilt head slightly forward, place tip of bottle into nose, compress bottle once for each spray, aiming towards the back of the nose.
1
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c599c4a0-705d-4ebb-ab1f-977af038f96a | Product name | 1 | 20251124 |
| c5cd4727-ac49-4409-82b1-5bd8006c3ec7 | Product name | 1 | 20171122 |
| 6cca4355-1206-91f7-02de-17eef38a8622 | Product name | 1 | 20140508 |
| 751c581a-bf64-2fd7-b3ec-ca02c83e4a00 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17089-451-23 | GUNA-SINUS NOSE | 30 mL in 1 BOTTLE, SPRAY | SPRAY | 30 | 3 | |
| 17089-451-23 | GUNA-SINUS NOSE | 1 in 1 BOX | SPRAY | 1 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17089-451 | GUNA-SINUS NOSE (ALTHAEA OFFICINALIS LEAF - ASCORBIC ACID - BLACK CURRANT - CALCIUM SULFIDE - COPPER - ECHINACEA ANGUSTIFOLIA - GOLDENSEAL - LACHESIS MUTA VENOM - LOBARIA PULMONARIA - MANGANESE - MERCURIC SULFIDE - ONION - PLANTAGO MAJOR - POTASSIUM CARBONATE - PULSATILLA VULGARIS - SILICON DIOXIDE - SILVER NITRATE - SINUSITISINUM - SUS SCROFA NASAL MUCOSA - SUS SCROFA THYMUS - SUS SCROFA URINARY BLADDER -) SPRAY [GUNA SPA] | 3 | Current NDC, Legacy NDC, 2 package rows | 20190404_36fef678-17c6-4d2a-a0f0-ddb298611f25.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALTHAEA OFFICINALIS LEAF | ACTIVE INGREDIENT | E2QQV92338 | 2 | |
| ASCORBIC ACID | ACTIVE INGREDIENT | PQ6CK8PD0R | 2 | |
| BLACK CURRANT | ACTIVE INGREDIENT | 9755T40D11 | 2 | |
| CALCIUM SULFIDE | ACTIVE INGREDIENT | 1MBW07J51Q | 2 | |
| COPPER | ACTIVE INGREDIENT | 789U1901C5 | 2 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE INGREDIENT | VB06AV5US8 | 2 | |
| GOLDENSEAL | ACTIVE INGREDIENT | ZW3Z11D0JV | 2 | |
| LACHESIS MUTA VENOM | ACTIVE INGREDIENT | VSW71SS07I | 2 | |
| LOBARIA PULMONARIA | ACTIVE INGREDIENT | D1YM0P5Z2T | 2 | |
| MANGANESE | ACTIVE INGREDIENT | 42Z2K6ZL8P | 2 | |
| MERCURIC SULFIDE | ACTIVE INGREDIENT | ZI0T668SF1 | 2 | |
| ONION | ACTIVE INGREDIENT | 492225Q21H | 2 | |
| PLANTAGO MAJOR | ACTIVE INGREDIENT | W2469WNO6U | 2 | |
| POTASSIUM DICHROMATE | ACTIVE INGREDIENT | T4423S18FM | 2 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 2 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| SILVER NITRATE | ACTIVE INGREDIENT | 95IT3W8JZE | 2 | |
| SINUSITISINUM | ACTIVE INGREDIENT | B575563DM5 | 2 | |
| SUS SCROFA NASAL MUCOSA | ACTIVE INGREDIENT | ID3Z1X61WY | 2 | |
| SUS SCROFA THYMUS | ACTIVE INGREDIENT | 7B69B0BD62 | 2 | |
| SUS SCROFA URINARY BLADDER | ACTIVE INGREDIENT | 3G7U72W8DA | 2 | |
| ALTHAEA OFFICINALIS LEAF | ACTIVE MOIETY | E2QQV92338 | 2 | |
| ASCORBIC ACID | ACTIVE MOIETY | PQ6CK8PD0R | 2 | |
| BLACK CURRANT | ACTIVE MOIETY | 9755T40D11 | 2 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 2 | |
| COPPER | ACTIVE MOIETY | 789U1901C5 | 2 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE MOIETY | VB06AV5US8 | 2 | |
| GOLDENSEAL | ACTIVE MOIETY | ZW3Z11D0JV | 2 | |
| LACHESIS MUTA VENOM | ACTIVE MOIETY | VSW71SS07I | 2 | |
| LOBARIA PULMONARIA | ACTIVE MOIETY | D1YM0P5Z2T | 2 | |
| MANGANESE | ACTIVE MOIETY | 42Z2K6ZL8P | 2 | |
| MERCURIC CATION | ACTIVE MOIETY | ED30FJ8Y42 | 2 | |
| ONION | ACTIVE MOIETY | 492225Q21H | 2 | |
| PLANTAGO MAJOR | ACTIVE MOIETY | W2469WNO6U | 2 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 2 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 2 | |
| SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 2 | |
| SILVER CATION | ACTIVE MOIETY | 57N7B0K90A | 2 | |
| SINUSITISINUM | ACTIVE MOIETY | B575563DM5 | 2 | |
| SUS SCROFA NASAL MUCOSA | ACTIVE MOIETY | ID3Z1X61WY | 2 | |
| SUS SCROFA THYMUS | ACTIVE MOIETY | 7B69B0BD62 | 2 | |
| SUS SCROFA URINARY BLADDER | ACTIVE MOIETY | 3G7U72W8DA | 2 | |
| ORANGE JUICE | INACTIVE INGREDIENT | 5A9KE2L9L3 | 2 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 2 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 17089-451 | 17089-451-23 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | 160 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAMUSCULAR | 864 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE, DENTIFRICE / DENTAL | 0.5 %w/w | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SPONGE / TOPICAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | FILM / BUCCAL | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYSTEM / TOPICAL | 2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | FILM, SOLUBLE / BUCCAL | 3 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / DENTAL | 0.08 %w/w | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / ORAL | 28 mg | ||
| ORANGE JUICE | ORANGE JUICE | 5A9KE2L9L3 | SOLUTION / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAMUSCULAR | 864 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, EFFERVESCENT / ORAL | 60 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION, EXTENDED RELEASE / ORAL | 24 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ENEMA / RECTAL | 60 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | 320 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION, SOLUTION / INTRAMUSCULAR | 4.8 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | 20 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CREAM / TOPICAL | 0.2 %w/w | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / TOPICAL | 0.1 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAVENOUS | 864 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, FOR SUSPENSION / ORAL | 120 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION, EXTENDED RELEASE / ORAL | 24 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION, EMULSION / INTRAVENOUS | 0.1 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | FILM / BUCCAL | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GEL / TOPICAL | 5 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION, SOLUTION / INTRAMUSCULAR | 4.8 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | FILM, SOLUBLE / BUCCAL | 3 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GEL / RECTAL | 406 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / DENTAL | 0.08 %w/w | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | 320 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / ORAL | 28 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, FOR SUSPENSION / ORAL | 120 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | 20 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAVENOUS | 864 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CREAM / TOPICAL | 0.2 %w/w | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GEL / TOPICAL | 5 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GUNA-SINUS NOSE | ALTHAEA OFFICINALIS LEAF - ASCORBIC ACID - BLACK CURRANT - CALCIUM SULFIDE - COPPER - ECHINACEA ANGUSTIFOLIA - GOLDENSEAL - LACHESIS MUTA VENOM - LOBARIA PULMONARIA - MANGANESE - MERCURIC SULFIDE - ONION - PLANTAGO MAJOR - POTASSIUM CARBONATE - PULSATILLA VULGARIS - SILICON DIOXIDE - SILVER NITRATE - SINUSITISINUM - SUS SCROFA NASAL MUCOSA - SUS SCROFA THYMUS - SUS SCROFA URINARY BLADDER - | Guna spa | 36fef678-17c6-4d2a-a0f0-ddb298611f25 | 2018-12-22 | Warnings | 17089-451-23 17089-451 17089045123 7d9d997a-fda9-2a63-e053-2a91aa0a0000 36fef678-17c6-4d2a-a0f0-ddb298611f25 |
Adverse event summaries are temporarily unavailable. Other product information remains available.